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Background: Paullinia pinnata L. (Sapindaceae) is an African woody vine, which is widely used in traditional
medicine for the treatment of human malaria, erectile dysfunction and bacterial infections. A phytochemical
investigation of its methanol leaf and stem extracts led to the isolation of seven compounds which were evaluated
for their antimicrobial properties.
Methods: The extracts were fractionated and compounds were isolated by chromatographic methods. Their
structures were elucidated from their spectroscopic data in conjunction with those reported in literature. The
antimicrobial activities of the crude extracts, fractions and compounds were evaluated against bacteria, yeasts and
dermatophytes using the broth micro-dilution technique.
Results: Seven compounds: 2-O-methyl-L-chiro-inositol (1), β-sitosterol (2), friedelin (3), 3β-(β-D-Glucopyranosyloxy)
stigmast-5-ene (4), (3β)-3-O-(2′-Acetamido-2′-deoxy-β-D-glucopyranosyl) oleanolic acid (5), (3β,16α-hydroxy)-3-O-(2′-
Acetamido-2′-deoxy-β-D-glucopyranosyl) echinocystic acid (6) and (3β)-3-O-[β-D-glucopyranosyl-(1″-3′)-2′-acetamido-
2′-deoxy-β-D-galactopyranosyl]oleanolic acid (7) were isolated. Compounds 5 and 7 showed the best antibacterial
and anti-yeast activities respectively (MIC value range of 0.78-6.25 and 1.56-6.25 μg/ml), while 6 exhibited the
best anti-dermatophytic activity (MIC value range of 6.25-25 μg/ml).
Conclusion: The results of the present findings could be considered interesting, taking into account the
global disease burden of these susceptible microorganisms, in conjunction with the search for alternative and
complementary medicines.
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Paullinia pinnata L. (Sapindaceae), an African woody
vine, whose leaves and roots are widely used in traditional
medicine for the treatment of human malaria [1] and
erectile dysfunction [2]. In the West Region of Cameroon,
its leaf decoction is used for the treatment of bacterial in-
fections like typhoid fever, syphilis, gonorrhea, diarrhea,
and symptoms like stomach-ache and waist pain. In East
Africa, the leaves are reported to be used in the treatment
of gonorrhea, wounds and microbial infections [3]. Previ-
ous phytochemical investigations have shown the presence* Correspondence: duzhizhi@mail.kib.ac.cn; gatsingd@yahoo.com
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unless otherwise stated.of triterpene saponins, cardiotonic catechol tannins [4,5],
flavone glycosides [6], steroids, steroidal glycosides [7],
cerebroside and ceramide [8], as well as fatty acids [1] in
P. pinnata collected from different parts of Africa.
There is a very limited biological investigation of the
chemical constituents from the title species P. pinnata.
As a result of our interest in the chemical and biological
investigation of this plant, a methylinositol (1), steroidal
terpenoids (2 and 4), and oleanane triterpenoids (3, 5–7)
were isolated from its leaf and stem methanol extracts. In
our previous studies, the antityphoid and antioxidant
properties of these compounds were evaluated [9]. The
extracts, fractions and all the compounds were evaluated
for their antimicrobial activities against eight bacteria, five
yeasts and five dermatophytes species and the results are
reported herein. Compounds 2 (β-sitosterol) and 4 (dau-
costerol) were formally isolated from P. pinnata leavesLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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ledge, 1, 3 and 5–7 are isolated from P. pinnata for the
first time, and the antimicrobial properties of 5–7 are pre-
sented here for the first time.
Methods
Plant material
The air-dried leaves and stems of P. pinnata were ob-
tained from Dschang, West Region of Cameroon, in
January 2009. The identification of plant specimens was
done at the Cameroon National Herbarium in Yaounde
by Mr Tadjouteu Fulbert, where a voucher specimen was
deposited under the reference number 10702/SRFCam.
Extraction and isolation
The air-dried leaves (2.04 Kg) and stems (2.02 kg) of P.
pinnata were powdered and extracted with MeOH
(7 l × 2, 48 h each) at room temperature to give crude
extracts (233.8 g and 152.17 g respectively) after concen-
tration under reduced pressure. The leaf extract (230 g)
was exhaustively and successively washed with n-hexane
and acetone to afford the hexane (45.2 g), acetone (8 g)
and methanol residue (156.8 g) fractions while the stem
extract was partitioned into petroleum ether, ethyl
acetate and water to obtain the PE fraction (8.08 g),
EtOAc fraction (9.13 g) and aqueous residue fraction
(109.89 g).
One hundred and fifty grams of the methanol residue
fraction was applied to neutral silica gel 60 (0.2-0.5 mm)
column (60 × 8 cm) and eluted with mixtures of n-
hexane-ethyl acetate and ethyl acetate-methanol of in-
creasing polarity (100:0→ 0:100 with constant polarity
increase of 5%). This gave 60 fractions which were
grouped on the basis of their TLC band pattern similar-
ities into 5 fractions (F1 to F5). Further column purifica-
tion of F2 (eluted with EtOAc-MeOH, 90:10) on silica
gel yielded six fractions denoted F2.1 to F2.6. Niddle-like
crystals, formed in F2.3 (EtOAc-MeOH, 95:5) and F2.4
(EtOAc-MeOH, 90:10) were collected and purified on a
sephadex gel (LH-20), eluted with an isocratic system of
CHCl3-MeOH (40:60) to afford 2-O-methyl-L-chiro-in-
ositol (1, 28 mg). Fourty grams of the hexane fraction
was applied to neutral silica gel 60 (0.2-0.5 mm) column
(60 × 8 cm) and eluted with a mixture of petroleum
ether-ethyl acetate of increasing polarity (100:0→ 50:50
with constant polarity increase of 5%) to give 40 frac-
tions. These fractions were further grouped on the basis
of their TLC band pattern similarities into 5 fractions
(F1 to F5). Fraction F1 (Petroleum ether 100%) was
mounted on a silica gel column and eluted with a mix-
ture of Hex-EtOAc of increasing polarity (95:5→ 50:50)
to yield 30 fractions which were equally grouped on the
basis of their TLC band pattern similarities into 5 sub
fractions (F1.1 to F1.5). Sub fractions F1.1 (Hex-EtOAc,90:10) and F1.4 (Hex-EtOAc, 65:35) both yielded white
powders which were purified by sephadex gel (LH-20)
column chromatography and eluted with CHCl3-MeOH
(4:6) to afford β-sitosterol (2, 20 mg). Finally, F2 (Petroleum
ether-EtOAc, 95:5) was mounted on a silica gel column
and eluted with a mixture of Hex-EtOAc of increasing po-
larity (95:5→ 70:30) to yield 10 fractions which were
grouped on the basis of their TLC band pattern similarities
into 3 sub fractions (F2.1 to F2.3). Sub fractions F2.1 (Hex-
EtOAc, 95:5) and F2.2 (Hex-EtOAc, 93:7) yielded transpar-
ent crystals which were purified by sephadex gel (LH-20)
column chromatography and eluted with CHCl3-MeOH
(4:6) to affordfriedelin (3, 18 mg).
The EtOAc fraction (7.07 g) was subjected to column chro-
matography on Rp-18 gel (MPLC, MeOH-H2O 50:50→
100:0) to afford 3β-(β-D-Glucopyranosyloxy) stigmast-5-
ene (4, 119 mg), (3β)-3-O-(2′-Acetamido-2′-deoxy-β-D-
glucopyranosyl) oleanolic acid (5, 170 mg) and 8 fractions.
Similarly, F4 (3.60 g) was chromatographed on silica gel
column and eluted with CHCl3-MeOH (9:1→ 7:3) to give
4 fractions. F4.4 (448 mg) was subjected to sephadex
LH-20 gel column chromatography and eluted with
CHCl3-MeOH (1:1) to afford (3β, 16α-hydroxy)-3-O-
(2′-Acetamido-2′-deoxy-β-D-glucopyranosyl) echinocystic
acid (6, 45 mg). The aqueous residue fraction (76.79 g)
was mounted on a D101 macroporous resin column and
eluted successively with H2O-EtOH (10:0; 7:3; 5:5; 3:7;
0:10) to obtain 5 fractions denoted F1 to F5 respectively.
F5 (946 mg) was purified on a silica gel column, eluted
with a stepwise gradient mixture of CHCl3-MeOH-H2O
(8:2:0.5→ 6:4:0.5) to afford (3β)-3-O-[β-D-glucopyranosyl-
(1″-3′)-2′-acetamido-2′-deoxy-β-D-galactopyranosyl]
oleanolic acid (7, 40 mg).
Identification of compounds
Optical rotations were measured with a JASCO P-1020
digital polarimeter. UV spectra were obtained using a
Shimadzu UV-2401 PC spectrophotometer. IR spectra
were recorded on a Bruker Tensor-27 infrared spectro-
photometer using KBr pellets. 1 day and 2D NMR spec-
tra were performed on Bruker AM-400 and DRX-500
spectrometers (BrukerBioSpinGmBH, Rheinstetten,
Germany) with TMS as the internal standard. ESIMS
spectra were recorded on a Bruker HTC/Esquire spec-
trometer. HREIMS was recorded on a Waters AutoSpec
Premier P776 spectrometer. Column Chromatography (CC)
was performed on silica gel (200–300 mesh, Qingdao
Marine Chemical Ltd., Qingdao, China), Rp-18 (40–
63 μm, Merk). Fractions were monitored by TLC (GF254,
Qingdao Marine Chemical Ltd., Qingdao, China), and
by heating silica gel plates sprayed with 10% H2SO4
in ethanol. GC analysis was performed on an HP5890
gas chromatograph equipped with a H2 flame ionization
detector.
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Compounds 4-7 (2 mg) were each refluxed with 2 M
HCl (1,4-dioxane/H2O 1:1, 2 ml) on water bath for 2 h.
After cooling, the reaction mixture was extracted with
CHCl3 (3 × 5 ml). The aqueous layer was evaporated to
dryness with MeOH until neutral. The dried residue
(sugar) was dissolved in 1 ml anhydrous pyridine and
treated with L-cysteine methyl ester hydrochloride
(1.5 mg), and stirred at 60°C for 1 h. Trimethylsilylimi-
dazole (1.0 ml) was added to the reaction mixture, and
this was kept at 60°C for 30 min. The resulting super-
natant (4 μl) was analyzed by GC under the following con-
ditions: H2 flame ionization detector; Column: 30QC2/
AC-5 quartz capillary column (30 m × 0.32 mm); Column
temperature: 180–280°C at the rate of 3°C/min;carrier
gas: N2 (1 ml/min); injector temperature: 250°C; split
ratio: 1/50. The configurations of D-glucose and D-
galactose for compounds 4–7 were determined by com-
parison of the retention times of their corresponding
derivatives with those of standard D-glucose and D-
galactose giving a single peak at 10.669 and 10.969 min,
respectively.
Antimicrobial assays
Microorganisms and culture media
The microorganisms used in this study were obtained
from the American Type Culture Collection (ATCC),
“EcoleNationaleVétérinaired’Alfort” (E), “centre Pasteur”
of Yaounde-Cameroon and “Institut Pasteur” of Paris-
France (IP). They includedeight bacteria strains: Salmon-
ella typhi ATCC 6539, Staphylococcus aureus ATCC
25922, Pseudomonas aeruginosa ATCC 27853, Klebsiella
pneumoniae ATCC 13883, Escherichia coli ATCC 10536,
Enterococcus faecalis ATCC 10541, Enterobacter aerogi-
nese ATCC 13048, Providensia smartii ATCC 29916; five
yeasts: Candida albicans ATCC 2091, Candida guilier-
mondii, Cryptococcus neoformans IP 90526, Candida luci-
teniae ATCC 200950 and Candida parapsilosis ATCC
22019 and five dermatophytes: Trichophyton equinum
E1424, Microsporium audouinii E1421,Trichophyton men-
tagrophytes E1425, Microsporium gypseum E1420 and Epi-
dermophyton flocosum.
The culture media, Nutrient Agar (NA, Conda) and
Sabouraud Dextrose Agar (SDA, Conda), were used for
culturing bacteria and fungi respectively, while Mueller
Hinton Broth (MHB, Conda), and Sabouraud Dextrose
Broth (SDB, Conda) were used for the determination
of minimum inhibitory and minimum microbicidal
concentrations.
Preparation of microbial inocula
The inocula of bacteria and yeasts were prepared from 24 h
and 48 h old agar cultures respectively. The absorbance was
read at 600 nm (Jenway 6105 UV/Vis spectrophotometer-50 Hz/60 Hz) and adjusted with sterile physiological solu-
tion to match that of a 0.5 McFarland standard solution.
From the prepared microbial solutions, other dilutions
with sterile physiological solution were prepared to give a
final concentration of 106 colony- forming units (CFU)
per milliliter for bacteria and 2 × 105 spores per milliliter
for yeasts [10].
Conidia suspensions of dermatophyte species were
prepared from 10 days old cultures. The number of co-
nidia was determined using a spectrophotometer and
adjusted with sterile saline (NaCl) solution (0.9%) to an
absorbance of 0.600 at 450 nm,corresponding to a final
concentration of about 1 × 105 spores/ml [11].
Determination of minimum inhibitory concentration (MIC)
and minimum microbicidal concentration (MMC)
The MICs of the samples were determined by the broth
microdilution method in 96-well micro-titre plates as
described in the literature elsewhere [12]. The 96-well
plates were prepared by dispensing into each well 100 μl
of Mueller Hinton broth for bacteria and Sabouraud
Dextrose broth for fungi. The test substances were ini-
tially prepared in 10% DMSO in broth medium and
100 μl of each test sample was added into the first wells
of the micro-titre plate (whose wells were previously
loaded with 100 μl of broth medium). Serial two-fold di-
lutions of the test samples were made and 100 μl of in-
oculum were then added into each well. This gave final
concentration ranges of 12500 to 6.10 μg/ml for extract
and fractions, 100 to 0.78 μg/ml for the compounds and
12.5 to 0.09 μg/ml for reference substances. The plates
were sealed with parafilm, then agitated with a plate
shaker to mix their contents and incubated at 35°C for
24 h for bacteria, 48 h for yeast and at 28°C for 7 days
for dermatophytes.
For bacteria, MICs were determined upon addition of
50 μl (0.2 mg/ml) p-iodonitrotetrazolium chloride (INT,
Sigma-Aldrich, South Africa). Viable bacteria reduced
the yellow dye to a pink color. For yeasts and dermato-
phytes, MICs were determined by visualizing the turbid-
ity of the wells. The MIC corresponded to the lowest
well concentration where no color/turbidity change was
observed, indicating no growth of microorganism. All
tests were performed in triplicates.
Minimum microbicidal concentrations were deter-
mined by adding 50 μl (for bacteria and yeasts) or 5 μl
(for dermatophytes) aliquots of the preparations (with-
out INT for bacteria), which did not show any visible
color/turbidity change after incubation during MIC as-
says, into 150 or 195 μl of sample-free broth. These
preparations were further incubated and revealed as
above to obtain the MMCs. Gentamycin, nystatin and
griseofulvin were used as positive controls for bacteria,
yeast and dermatophytes respectively.
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The following known compounds: 2-O-methyl-L-chiro-
inositol (1) [13] whose 13C NMR data were very close to
those of L-quebrachitol [14,15], β-sitosterol (2) [16], frie-
delin (3) [17,18] (Figure 1) were isolated and identified in
the leaves of P. pinnata. From the MeOH stem- extract,
3β-(β-D-Glucopyranosyloxy) stigmast-5-ene or daucosterol
(4) [19], 3-O-(2′-acetamido-2′-deoxy-β-D-glucopyranosyl)
olean-12-en-28-oic acid or aridanin (5) [20,21], 3-O-(2-
acetamido-2′deoxy-β-D-glucopyranosyl)-l6α-hydroxyolean-
l2-en-28-oic acid (6) [20] and 3-O-[β-D-glucopyranosyl-
(1″-3′)-2′-acetamido-2′-deoxy-β-D-galactopyranosyl]
olean-12-en-28-oic acid or lotoidoside E (7) [22] were iso-
lated and identified (Figure 1). The compounds isolated in
the present study were formerly isolated from other plants
and the biological activities of some were demonstrated
[23,24]. Besides, in our previous investigation, their antity-
phoid and antioxidant properties were demonstrated [9].
P. pinnata extract have been proven to possess antioxi-
dant [25] and vascular relaxation [2] properties.
The antimicrobial properties of the extracts, fractions
and isolated compounds of the leaves and stems of P.
pinnata are presented in Tables 1 and 2 respectively. In
general, the crude extract of the leaves presented a bet-
ter antibacterial activity compared to the stem extract;
both of whose activities were comparable and not sig-
nificant on fungi especially on dermatophytes. The re-
sults show that Compound 5 and 7 exhibited significant



































Figure 1 Chemical structures of compounds from the leaves (1–3) anvalue range of 0.78-6.25 and 1.56-6.25 μg/ml), while 6
exhibited the best anti-dermatophytic activity (MIC
value range of 6.25-25 μg/ml). 1 was the most active
antibacterial compound from the leaves, but was less ac-
tive compared to 5. No compound from the leaves ex-
hibited antifungal activity at the tested concentration.
This probably explains why P. pinnata is not used by the
local population in the treatment of fungal infections,
since the leaf is the part locally used. β-sitosterol (2) was
formally isolated from Citrus grandis fruits and shown
to possess activity against gram-positive (Bacillus cereus,
Bacillus subtilis and Staphylococcus aureus) and gram-
negative (Escherichia coli and Salmonella enteritidis)
bacteria, with MIC value of 300 μg/ml [26]. Friedelin (3),
isolated from the stem bark of Vismia rubescens demon-
strated antibacterial activity against Salmonella typhi,
Staphylococcus aureus, Pseudomonas aeruginosa with MIC
values of 25–200 μg/ml [27]. Besides, daucosterol (4) is a
known antibacterial compound [28]
In general, the antifungal activities of isolated com-
pounds were relatively lower than their antibacterial activ-
ities. However 7 exhibited significant anti-yeast activity
(MIC value range of 0.78-6.25 μg/ml), while 6 exhibited
the best anti-dermatophytic activity (MIC value range of
6.25-25 μg/ml). Compounds 6 and 7 showed a wide
spectrum of action on all the three types of microorgan-
isms tested. Compounds 1, 3 and 5–7 are isolated from
P. pinnata for the first time and the antimicrobial activ-


























d stems (4–7) of P. pinnata.
Table 1 Minimum inhibitory and cidal concentrations (μg/ml) of the extract, fractions and compounds from the leaves
of P. pinnata against bacteria and fungi
Microorganism Extracta Hf Af MRf 1 2 3 RD
Bacteria
S. aureus MIC 390 97 195 48 50 / / 0.781
MBC 390 390 390 97 / / / 3.125
P. aeruginosa MIC 390 195 781 781 6.25 / 100 0.781
MBC 1562 781 1562 1562 50 / 100 1.562
K. pneumonia MIC 195 390 97 781 12.5 / 50 6.25
MBC 390 1562 781 1562 100 / 100 6.25
E. coli MIC 48 24 12 12 0.781 100 50 0.781
MBC 195 97 48 24 12.5 / 50 0.781
E. faecalis MIC 195 390 390 1562 12.5 / / 6.25
MBC 195 781 1562 1562 50 / / 6.25
E. aeroginese MIC 97 195 24 48.8 50 25 50 1.562
MBC 390 390 97 195 / 100 50 1.562
P. smartii MIC 48 48 97 12 6.25 100 50 0.781
MBC 195 390 390 48 100 / 50 0.781
Yeasts
C. albicans MIC 3125 1562 3125 / / / / 3.125
MFC 12500 6250 6250 / / / / 3.125
C. guiliermondii MIC 3125 781 781 3125 / / / 6.25
MFC 12500 6250 6250 / / / / 12.5
C. neoformans MIC 1562 195 97 3125 / / / 1.562
MFC 6250 390 390 / / / / 3.125
C. luciteniae MIC 3125 195 195 3125 / / / 3.125
MFC 12500 390 781 / / / / 6.25
C. parapsilosis MIC 6250 781 781 / / / / 3.125
MFC 12500 6250 6250 / / / / 3.125
Dermatophytes
T. equinum MIC 12500 390 390 / / / / 6.25
MFC / 1562 3125 / / / / 12.5
M. audouinii MIC 6250 390 781 / / / / 6.25
MFC 12500 1562 3125 / / / / 6.25
T. mentagrophytes MIC / 781 781 / / / / 3.125
MFC / 3125 3125 / / / / 6.25
M. gypseum MIC 12500 390 781 / / / / 6.25
MFC / 1562 3125 / / / / 12.5
E. flocosum MIC 12500 390 781 / / / / 3.125
MFC / 1562 3125 / / / / 6.25
Extracta: leaf extract; Hf: Hexane fraction; Af: Acetone fraction; MRf; Methanol residue fraction; RD: reference drug (Gentamycin, Nystatine and Griseofulvin for
bacteria, yeasts and dermatophytes respectively); /: not active (at 12500 μg/ml for extract and fractions, and 100 μg/ml for compounds).
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tifungal activities. The structure-activity relationship of
compound 5 and its analogue 6, shows that the introduc-
tion of an -OH group at C-16 in compound 6 consider-
ably reduced its antibacterial activity, and increased itsantifungal activities against the above mentioned microbial
strains. The structures of 5 and 7 are similar, 7 showed
more antifungal activity compared to 5 against the tested
fungal species. This suggests that the introduction of a
β-D-galactopyranose group at C-3′ of the sugar moiety
Table 2 Minimum inhibitory and cidal concentrations (μg/ml) of the extract, fractions and compounds from the stem
of P pinnata against bacteria and fungi
Microorganism Test substance
Extractb PEf EAf ARf 4 5 6 7 RD
Bacteria
S. aureus MIC 781 1562 195 390 25 1.562 6.25 3.125 0.781
MBC 781 3125 390 1562 100 1.562 6.25 6.25 3.125
P. aeruginosa MIC 781 781 390 781 100 3.125 50 6.25 0.781
MBC 1562 3125 781 1562 / 6.25 100 12.5 1.562
K. pneumonia MIC 781 781 390 781 25 6.25 12.5 6.25 6.25
MBC 781 3125 781 1562 25 6.25 12.5 6.25 6.25
E. coli MIC 24 781 97 195 25 0.781 3.125 3.125 0.781
MBC 390 781 97 195 25 0.781 6.25 6.25 0.781
E. faecalis MIC 390 3125 781 1562 / 6.25 12.5 25 6.25
MBC 3125 6250 1562 1562 / 6.25 12.5 100 6.25
E. aeroginese MIC 390 390 97 195 25 0.781 6.25 12.5 1.562
MBC 781 781 195 390 50 1.562 12.5 25 1.562
P. smartii MIC 97 390 48.8 390 6.25 0.781 3.125 1.562 0.781
MBC 195 1562 195 781 12.5 0. 781 6.25 3.125 0.781
Yeasts
C. albicans MIC / 1562 781 3125 / / 3.125 3.125 3.125
MFC / 3125 781 3125 / / 6.25 6.25 3.125
C. guiliermondii MIC 12500 1562 195 3125 / / 3.125 1.5625 6.25
MFC 12500 6250 195 6250 / / 12.5 1.5625 12.5
C. neoformans MIC 3125 3125 195 3125 / / 3.125 1.5625 1.562
MFC 6250 3125 390 3125 / / 12.5 6.25 3.125
C. luciteniae MIC 3125 1562 97.7 781 / / 3.125 3.125 3.125
MFC 6250 1562 195 1562 / / 3.125 6.25 6.25
C. parapsilosis MIC 6250 1562 390 1562 / / 6.25 6.25 3.125
MFC 12500 3125 390 1562 / / 25 12.5 3.125
Dermatophytes
T. equinum MIC 12500 390 390 3125 50 50 25 50 6.25
MFC / 1562 390 3125 100 100 25 50 12.5
M. audouinii MIC 12500 781 390 3125 25 / 6.25 12.5 6.25
MFC / 1562 781 / 25 / 12.5 25 6.25
T. mentagrophytes MIC 12500 390 390 781 25 50 25 50 3.125
MFC / 390 781 1562 50 / 25 50 6.25
M. gypseum MIC 12500 390 195 781 12.5 25 6.25 25 6.25
MFC 12500 1562 195 781 50 25 25 25 12.5
E. flocosum MIC 12500 390 195 781 25 / 12.5 50 3.125
MFC 12500 781 390 3125 25 / 25 100 6.25
Extractb: stem extract; PEf: Petroleum ether fraction; EAf: ethylacetate fraction; ARf; aqueous residue fraction; RD: reference drug (Gentamycin, Nystatine and
Griseofulvin for bacteria, yeasts and dermatophytes respectively); /: not active (at 12500 μg/ml for extract and fractions, and 100 μg/ml for compounds).
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paring the MIC and MMC values of compounds 2 and 4,
it is seen that the presence of the C-3- β-D-glucopyranose
group in 4 considerably increased the antimicrobial activityof the latter. Thus, the presence or absence of C-16-OH,
C-3′- or C-3-β-D-hexopyranose groups play a critical role
in determining the specific antimicrobial property of these
types of oleanane triterpenoids and steroidal terpenes. The
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with respect to all the microorganisms studied, indicative
of a possible bactericidal nature of these compounds [29].
Moreso, the activities of compounds 6 and 7 were compar-
able to or better than the reference antibiotics on a consid-
erable number of the tested microorganisms.
Conclusion
The results of the present findings could be considered in-
teresting, taking into account the global disease burden of
these susceptible microorganisms, in conjunction with the
search for alternative and complementary medicines. They
also show that an antifungal formulation could henceforth
be envisaged from the stems of P. pinnata.
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